106
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The NLRP3 inflammasome: molecular activation and regulation to therapeutics

      research-article
      1 , 2 , 3 , 3 , 4 , 5 , 6
      Nature reviews. Immunology

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          NLRP3 (NACHT, LRR and PYD domains-containing protein 3) is an intracellular sensor that detects a broad range of microbial motifs, endogenous danger signals and environmental irritants, resulting in the formation and activation of the NLRP3 inflammasome. Assembly of the NLRP3 inflammasome leads to caspase-1-dependent release of the proinflammatory cytokines, IL-1β and IL-18, as well as to gasdermin D-mediated pyroptotic cell death. Recent studies have revealed new regulators of the NLRP3 inflammasome, including new interacting or regulatory proteins, metabolic pathways and a regulatory mitochondrial hub. In this Review, we present the molecular, cell biological and biochemical basis of NLRP3 activation and regulation, and describe how this mechanistic understanding is leading to potential therapeutics that target the NLRP3 inflammasome.

          Related collections

          Author and article information

          Journal
          101124169
          27017
          Nat Rev Immunol
          Nat Rev Immunol
          Nature reviews. Immunology
          1474-1733
          1474-1741
          18 December 2020
          August 2019
          14 January 2021
          : 19
          : 8
          : 477-489
          Affiliations
          [1 ]Department of Medicine, Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
          [2 ]Oral and Craniofacial Biomedicine Program, School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
          [3 ]Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
          [4 ]Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
          [5 ]Institute for Inflammatory Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
          [6 ]Center for Translational Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
          Author notes

          All the authors contributed equally to all aspects of the article.

          Correspondence to J.P.-Y.T. jenny_ting@ 123456med.unc.edu
          Article
          PMC7807242 PMC7807242 7807242 nihpa1655118
          10.1038/s41577-019-0165-0
          7807242
          31036962
          f2bf20e2-421c-452c-99fd-905c97883f21
          History
          Categories
          Article

          Comments

          Comment on this article